NCT04249882View on ClinicalTrials.gov

A Novel Human Lab Model for Screening AUD Medications

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 28, 2020

Primary Completion Date

June 28, 2022

Study Completion Date

June 28, 2022

Conditions
Alcohol Use Disorder
Interventions
DRUG

Placebo

Matched to active medication

DRUG

Naltrexone

50 mg once a day

DRUG

Varenicline

1 mg twice a day

Trial Locations (1)

90095

UCLA Addictions Lab, Los Angeles

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of California, Los Angeles

OTHER

NCT04249882 - A Novel Human Lab Model for Screening AUD Medications | Biotech Hunter | Biotech Hunter